Vale Biolabs
Vale Biolabs combines lab-grown human brain tissue, automation and predictive AI to improve research into neurological diseases, evaluate potential treatments and support the development of new therapies.
Vale Biolabs has raised €164k across 1 funding round from 1 investor, most recently a round in Nov 2026. Based in Zurich, Switzerland; active in Healthtech. Data as of Nov 2026.
Total raised
€164k
€163,684
Funding rounds
1
Investors
1
distinct backers
Active since
2026-11
latest 2026-11
Funding by year
EUR raised per year · 2026 YTDVale Biolabs — funding by year — interactive chart.
Data table
| Vale Biolabs — funding by year | |
|---|---|
| 2026 | €164k |
Signals
High confidenceRaise-next likelihood10
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-11-09 | Other | €164k | Venture Kick | View deal → |
Investors
1Related news
Similar companies
same sector, similar size- SurgExplore€164kSwitzerland · Healthtech
- NanoZymeX€164kSwitzerland · Healthtech
- TightValve€166kSwitzerland · Healthtech
- Eldian Biomed€166kSwitzerland · Healthtech
- Dexterous Endoscopes€166kSwitzerland · Healthtech
- hephaistos.bio€161kSwitzerland · Healthtech
Global coverage: FundingData